Company Filing History:
Years Active: 2023
Title: Innovations by Urich-Peter Rohr in Colorectal Cancer Prediction
Introduction
Urich-Peter Rohr is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of cancer prediction. His innovative approach focuses on non-invasive methods that can greatly enhance patient care.
Latest Patents
Urich-Peter Rohr holds a patent for a non-invasive test designed to predict the recurrence of colorectal cancer. This invention involves a method that analyzes circulating tumor DNA from a patient's sample following surgery. The ability to predict cancer recurrence through such a method represents a significant advancement in oncology.
Career Highlights
Rohr is currently associated with Roche Sequencing Solutions, Inc., a leading company in the field of genetic testing and diagnostics. His work at Roche emphasizes the importance of innovative solutions in improving patient outcomes and advancing medical technology.
Collaborations
Urich-Peter Rohr has collaborated with esteemed colleagues such as Hans-Peter Adams and Aarthi Balasubramanyam. These partnerships highlight the collaborative nature of research and development in the medical field.
Conclusion
Urich-Peter Rohr's contributions to the prediction of colorectal cancer recurrence through innovative methods exemplify the impact of research and invention in healthcare. His work continues to pave the way for advancements in cancer diagnostics and patient management.